Acadia Pharmaceuticals buy Mizuho
Start price
06.11.23
/
50%
€22.40
Target price
06.11.24
€32.59
Performance (%)
-30.29%
Price
26.04.24
€15.62
Summary
This prediction is currently active. The BUY prediction by Mizuho for Acadia Pharmaceuticals is performing very badly with a performance of -30.29%. This prediction currently runs until 06.11.24. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | - | - |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Mizuho for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $20.00.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Mizuho for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€36.02
28.02.25
28.02.25
-27.71%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.12.23
29.12.23
€36.19
29.12.24
29.12.24
-45.02%
26.04.24
26.04.24